Clinical tryals of tolerability and safety of lyophilic «Layfferon»,9 000 000 IU for intramuscular solution with participation of healthy volunteers

Автор: Ryndyuk N.N., Ginko Z.I., Aleynikov R.P., Vasilevich I.V., Kuzubov V.I., Usova S.V., Muhina O.N., Sharypova M.G., Targonskiy S.I.

Журнал: Клиническая практика @clinpractice

Рубрика: Оригинальные исследования

Статья в выпуске: 4 (4), 2010 года.

Бесплатный доступ

In the article results of clinical tryal of the new drug containing interferon – Layfferon, 9000000 IUintramuscular solution in healthy volunteers are presented.Safety and tolerability of the new dosage of Layfferon was estimated on the basis of supervision over a condition of volunteers, clinical and laboratory inspection within 30 day after introduction of a preparation.As a result of test it has been established, that Layfferone a doze 9 000 000 IUt is safe and tolerated. Study results have allowed to create the instruction on application for new dosage of the drug.

Clinical trials, safety, layfferon, tolerability

Короткий адрес: https://sciup.org/14338350

IDR: 14338350

Статья научная